IL93324A - Release means for administering pharmaceutical preparations orally - Google Patents
Release means for administering pharmaceutical preparations orallyInfo
- Publication number
- IL93324A IL93324A IL9332490A IL9332490A IL93324A IL 93324 A IL93324 A IL 93324A IL 9332490 A IL9332490 A IL 9332490A IL 9332490 A IL9332490 A IL 9332490A IL 93324 A IL93324 A IL 93324A
- Authority
- IL
- Israel
- Prior art keywords
- tube
- therapeutic agent
- grid
- dose
- outlet end
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 140
- 229940124597 therapeutic agent Drugs 0.000 title claims abstract description 119
- 239000007788 liquid Substances 0.000 claims abstract description 42
- 210000000214 mouth Anatomy 0.000 claims abstract description 36
- 239000002245 particle Substances 0.000 claims abstract description 24
- 239000002552 dosage form Substances 0.000 claims description 25
- 239000012530 fluid Substances 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 18
- 239000010902 straw Substances 0.000 claims description 15
- 239000008188 pellet Substances 0.000 claims description 14
- 230000035622 drinking Effects 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 1
- 230000009471 action Effects 0.000 abstract description 10
- 230000000717 retained effect Effects 0.000 abstract description 5
- 238000000576 coating method Methods 0.000 description 21
- 239000011248 coating agent Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 239000000203 mixture Substances 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 239000013543 active substance Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 239000002775 capsule Substances 0.000 description 8
- 239000006186 oral dosage form Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 238000010276 construction Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- -1 polypropylene Polymers 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000013268 sustained release Methods 0.000 description 6
- 239000012730 sustained-release form Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 description 5
- 229960002620 cefuroxime axetil Drugs 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 230000000873 masking effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000007908 dry granulation Methods 0.000 description 3
- 239000012669 liquid formulation Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 229920003148 Eudragit® E polymer Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- NEDGUIRITORSKL-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;2-(dimethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C.CN(C)CCOC(=O)C(C)=C NEDGUIRITORSKL-UHFFFAOYSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 235000021058 soft food Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 description 1
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- SGUAFYQXFOLMHL-UHFFFAOYSA-N 2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide Chemical compound C=1C=C(O)C(C(N)=O)=CC=1C(O)CNC(C)CCC1=CC=CC=C1 SGUAFYQXFOLMHL-UHFFFAOYSA-N 0.000 description 1
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229930195708 Penicillin V Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229960004538 alprazolam Drugs 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000004004 anti-anginal agent Substances 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003561 anti-manic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940124345 antianginal agent Drugs 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000000228 antimanic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002579 antinauseant Substances 0.000 description 1
- 229940125688 antiparkinson agent Drugs 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960002274 atenolol Drugs 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229960000725 brompheniramine Drugs 0.000 description 1
- ZDIGNSYAACHWNL-UHFFFAOYSA-N brompheniramine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 ZDIGNSYAACHWNL-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 description 1
- 229960005361 cefaclor Drugs 0.000 description 1
- 229960004841 cefadroxil Drugs 0.000 description 1
- NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960004621 cinoxacin Drugs 0.000 description 1
- VDUWPHTZYNWKRN-UHFFFAOYSA-N cinoxacin Chemical compound C1=C2N(CC)N=C(C(O)=O)C(=O)C2=CC2=C1OCO2 VDUWPHTZYNWKRN-UHFFFAOYSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 229940047766 co-trimoxazole Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960004100 dirithromycin Drugs 0.000 description 1
- WLOHNSSYAXHWNR-NXPDYKKBSA-N dirithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 WLOHNSSYAXHWNR-NXPDYKKBSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 238000013265 extended release Methods 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960004801 imipramine Drugs 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229960001977 loracarbef Drugs 0.000 description 1
- JAPHQRWPEGVNBT-UTUOFQBUSA-M loracarbef anion Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C([O-])=O)=O)N)=CC=CC=C1 JAPHQRWPEGVNBT-UTUOFQBUSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960004535 oxazepam Drugs 0.000 description 1
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229960002035 penbutolol Drugs 0.000 description 1
- KQXKVJAGOJTNJS-HNNXBMFYSA-N penbutolol Chemical compound CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1 KQXKVJAGOJTNJS-HNNXBMFYSA-N 0.000 description 1
- 229940056367 penicillin v Drugs 0.000 description 1
- 239000008014 pharmaceutical binder Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
- 229960002508 pindolol Drugs 0.000 description 1
- PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 229940126589 solid medicine Drugs 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000006068 taste-masking agent Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960004605 timolol Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0038—Straws
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47G—HOUSEHOLD OR TABLE EQUIPMENT
- A47G21/00—Table-ware
- A47G21/18—Drinking straws or the like
- A47G21/183—Drinking straws or the like with means for changing the flavour of the liquid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31263689A | 1989-02-17 | 1989-02-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL93324A0 IL93324A0 (en) | 1990-11-29 |
| IL93324A true IL93324A (en) | 1994-02-27 |
Family
ID=23212351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9332490A IL93324A (en) | 1989-02-17 | 1990-02-08 | Release means for administering pharmaceutical preparations orally |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4981468A (da) |
| EP (1) | EP0383503B1 (da) |
| JP (1) | JPH02274252A (da) |
| KR (1) | KR900012591A (da) |
| AT (1) | ATE91878T1 (da) |
| AU (1) | AU625179B2 (da) |
| CA (1) | CA2009858A1 (da) |
| DE (1) | DE69002345T2 (da) |
| DK (1) | DK0383503T3 (da) |
| ES (1) | ES2043268T3 (da) |
| HU (1) | HUT57573A (da) |
| IE (1) | IE63590B1 (da) |
| IL (1) | IL93324A (da) |
| NZ (1) | NZ232482A (da) |
| ZA (1) | ZA90945B (da) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5900250A (en) * | 1992-05-13 | 1999-05-04 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutnin |
| US5318520A (en) * | 1992-10-16 | 1994-06-07 | Nakao Naomi L | Safety method and device for intravenous feed systems |
| JP3688293B2 (ja) * | 1993-09-29 | 2005-08-24 | アルザ・コーポレーション | モノグリセリド／乳酸エステル透過促進剤 |
| US5780058A (en) * | 1995-07-21 | 1998-07-14 | Alza Corporation | Oral delivery of discrete units |
| AU742022B2 (en) * | 1995-07-21 | 2001-12-13 | Alza Corporation | Oral delivery of discrete units |
| DE69612098T2 (de) * | 1995-07-21 | 2001-06-21 | Alza Corp | Vorrichtung zur oralen verabreichung von diskreten einheiten |
| US5707353A (en) * | 1995-12-21 | 1998-01-13 | Abbott Laboratories | Oral administration of beneficial agents |
| AU721882B2 (en) * | 1996-10-10 | 2000-07-13 | Club Investments (Aust) Pty Ltd | Method and apparatus for producing a flavoured beverage |
| US20030087005A1 (en) * | 1996-10-10 | 2003-05-08 | Peter Baron | Drink flavouring straw |
| AUPS270602A0 (en) * | 2002-05-31 | 2002-06-20 | Baron, Peter | Drink flavouring straw |
| US6024721A (en) | 1996-10-18 | 2000-02-15 | Alza Corporation | Mixing system for an active agent delivery device |
| US6096003A (en) * | 1996-10-18 | 2000-08-01 | Alza Corporation | Closure system for an active agent delivery device |
| PT936893E (pt) | 1996-10-18 | 2001-12-28 | Alza Corp | Dispositivo com multiplos percursos de escoamento para a administracao oral de unidades discretas |
| WO1998034598A2 (en) * | 1997-02-07 | 1998-08-13 | Gist-Brocades B.V. | Homogeneous granulated formulations for dose sipping technology |
| PT984762E (pt) | 1997-05-16 | 2002-12-31 | Alza Corp | Configuracoes de controlador de debito para um dispositivo de administracao de agente activo |
| US20040062802A1 (en) * | 1998-04-02 | 2004-04-01 | Hermelin Victor M. | Maximizing effectiveness of substances used to improve health and well being |
| US5945123A (en) * | 1998-04-02 | 1999-08-31 | K-V Pharmaceutical Company | Maximizing effectiveness of substances used to improve health and well being |
| WO2000025744A1 (en) * | 1998-10-30 | 2000-05-11 | Mcneil-Ppc, Inc. | Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof |
| US6217545B1 (en) | 1999-02-08 | 2001-04-17 | Porex Technologies Corp. | Filter with varying density which is responsive to fluid flow |
| US6544555B2 (en) * | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| NZ521034A (en) | 2000-02-28 | 2004-08-27 | Vectura Ltd | Improvements in or relating to the delivery of oral drugs |
| US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| DE10228173A1 (de) * | 2002-03-27 | 2003-10-09 | Gruenenthal Gmbh | System zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen |
| DE10228175A1 (de) * | 2002-03-27 | 2003-10-09 | Gruenenthal Gmbh | Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen |
| US20050118245A1 (en) * | 2002-03-27 | 2005-06-02 | Wilsmann Klaus M. | Assembled unit consisting of individually separable, transdermal, therapeutic systems |
| DE10228179A1 (de) * | 2002-06-24 | 2004-01-22 | Grünenthal GmbH | Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen |
| DE10228171A1 (de) * | 2002-06-24 | 2004-01-22 | Grünenthal GmbH | Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen |
| DE10228192A1 (de) * | 2002-06-24 | 2004-01-15 | Grünenthal GmbH | Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen |
| DE10228176A1 (de) * | 2002-06-24 | 2004-01-22 | Grünenthal GmbH | Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen |
| US7524515B2 (en) * | 2003-01-10 | 2009-04-28 | Mutual Pharmaceuticals, Inc. | Pharmaceutical safety dosage forms |
| DE10308175A1 (de) * | 2003-02-25 | 2004-09-02 | Grünenthal GmbH | Darreichungsform und Kit zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen |
| US6966252B2 (en) * | 2003-03-31 | 2005-11-22 | Mcneil-Ppc, Inc. | Hydrophilic substance dispensing device |
| CN1787797A (zh) * | 2003-05-14 | 2006-06-14 | 株式会社吴羽 | 口服用固态成形物的吞咽用收纳体,该收纳体用容器及吞咽方法 |
| US20040253351A1 (en) * | 2003-06-11 | 2004-12-16 | Killips Lynn Ramblas | Apparatus and method for mixing confectionary with fluids |
| DE10342514A1 (de) * | 2003-09-12 | 2005-04-07 | Grünenthal GmbH | Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen, Kit und Verwendung |
| DE10342513A1 (de) * | 2003-09-12 | 2005-05-12 | Gruenenthal Gmbh | Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen, Kit und Verwendung |
| US20050103879A1 (en) * | 2003-11-19 | 2005-05-19 | Robinson Ted R. | Straw |
| US20050116057A1 (en) * | 2003-12-01 | 2005-06-02 | Hamer Douglas T. | Novelty beverages straw |
| US7431175B2 (en) * | 2004-07-16 | 2008-10-07 | Roger Heilos | Drinking cup lid for assisting in ingestion of medication |
| US20070051741A1 (en) * | 2005-09-02 | 2007-03-08 | Kraft Foods Holdings, Inc. | Methods for the application of ingredients to the inside of a straw |
| NL1031129C2 (nl) * | 2005-12-01 | 2007-06-04 | Asepticstraw Internat B V | Artikel voor het bewegen van een medium voor te eten en/of drinken. |
| WO2008085764A1 (en) * | 2007-01-05 | 2008-07-17 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
| AR060029A1 (es) * | 2006-03-02 | 2008-05-21 | Unistraw Patent Holdings Ltd | Pajilla para beber adaptada para acondicionar progresivamente un ingrediente activo y metodo de fabricar dicha pajilla |
| US20080075809A1 (en) * | 2006-09-21 | 2008-03-27 | Anderson Michael R | Drinking straw for dispensing substances with one-way valve |
| US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| US20080197141A1 (en) * | 2007-02-20 | 2008-08-21 | Felfoldi Edesseggyarto Kft. | Drinking Straw |
| WO2008112388A1 (en) * | 2007-03-14 | 2008-09-18 | Drugtech Corporation | Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals |
| JP5264882B2 (ja) * | 2007-04-10 | 2013-08-14 | サンド アクチエンゲゼルシャフト | 物質の経口投与のための装置 |
| FR2920308B1 (fr) * | 2007-09-05 | 2011-02-25 | Unither Dev | Forme pharmaceutique pour l'administration par voie orale de principes actifs. |
| US7997509B2 (en) * | 2008-04-08 | 2011-08-16 | Dana Karklins | Portion-controlled dispensing straw assembly |
| PL2349222T3 (pl) * | 2008-09-10 | 2017-08-31 | Sandoz Ag | Kapsułka z rozpuszczalnym elementem blokującym |
| GB2480827B (en) * | 2010-06-01 | 2012-06-06 | Kraft Foods R & D Inc | Improvements in the preparation of beverages and liquid food products |
| JP6210988B2 (ja) | 2011-09-19 | 2017-10-11 | オレクソ・アクチエボラゲット | オピオイド依存を治療するための新規乱用耐性医薬組成物 |
| US9017749B2 (en) | 2011-12-21 | 2015-04-28 | Babatope Sewande Ayeni | Flavored straw with a flavor delivery system |
| US8834449B2 (en) * | 2012-01-23 | 2014-09-16 | Ikomed Technologies, Inc. | Mixing syringe |
| US9751056B2 (en) | 2012-01-23 | 2017-09-05 | Merit Medical Systems, Inc. | Mixing syringe |
| ES2649140T3 (es) | 2012-07-05 | 2018-01-10 | P.C.O.A. Devices Ltd. | Dispensador de medicación |
| ES2649142T3 (es) * | 2012-07-30 | 2018-01-10 | P.C.O.A. Devices Ltd. | Recipiente para contener y dispensar pastillas medicinales sólidas |
| US20140343487A1 (en) * | 2013-05-14 | 2014-11-20 | Semion Hlebnikov | Drinking straw that contains substances for treating the side effects of alcohol consumption |
| CA2936740C (en) | 2014-10-31 | 2017-10-10 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| WO2016193242A1 (en) * | 2015-06-01 | 2016-12-08 | Unistraw Holdings Pte. Ltd. | Formulations of cns-stimulants and vitamins |
| US20180133108A1 (en) * | 2015-06-10 | 2018-05-17 | Unistraw Holdings Pte. Ltd. | Drinking straw with internal coating |
| ES2842124T3 (es) * | 2015-12-22 | 2021-07-12 | Alterno Labs D O O | Pajita de beber precargada con un cierre de válvula de ranura transversal en ambos extremos |
| US12419451B2 (en) | 2017-06-20 | 2025-09-23 | Alterno Labs D.O.O. | Pre-filled drinking straw with a cross-slit valve closure on both ends |
| WO2020021111A1 (en) * | 2018-07-27 | 2020-01-30 | Sisteks D.O.O. | Straw for oral administration of pharmaceutical formulation |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| CN111407663B (zh) | 2019-01-07 | 2026-01-02 | 上海汉都医药科技有限公司 | 一种口服给药递送装置 |
| US20220257471A1 (en) | 2019-09-30 | 2022-08-18 | Shanghai Wd Pharmaceutical Co., Ltd | Drug accommodating device of solid oral formulation, and oral administration and delivery apparatus comprising same |
| AU2020448180A1 (en) | 2020-05-18 | 2022-12-15 | air up group GmbH | Aroma container and drinking device having an aroma container |
| US11272799B2 (en) | 2020-05-29 | 2022-03-15 | Unistraw Corp. | Drinking straw with internal coating |
| EP3944792A1 (de) * | 2020-07-30 | 2022-02-02 | air up group GmbH | Trinkvorrichtung und trinkgefäss |
| US20230414454A1 (en) * | 2022-06-23 | 2023-12-28 | Michael William Babb | Medication or vitamin swallowing aid |
| US20250302218A1 (en) * | 2024-03-30 | 2025-10-02 | Red River Tea Company | Container straw, beverage kit, method for preparing the beverage kit, and method of using the beverage kit |
| WO2025221761A2 (en) * | 2024-04-17 | 2025-10-23 | Genzyme Corporation | Medicament container and kit for reconstituting a lyophilized medicament |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US430928A (en) * | 1890-06-24 | Device for administering medicine to animals | ||
| US580527A (en) * | 1897-04-13 | Drinking-tube | ||
| US121684A (en) * | 1871-12-05 | Improvement in devices for administering pills | ||
| US697209A (en) * | 1901-07-24 | 1902-04-08 | Benno Koppenhagen | Device for facilitating taking pills. |
| US1236029A (en) * | 1916-08-10 | 1917-08-07 | George H Williams | Drinking device. |
| US1685280A (en) * | 1927-07-16 | 1928-09-25 | Lester L Findley | Powder-placing syringe |
| US2436505A (en) * | 1945-08-24 | 1948-02-24 | Rall John H Du | Pill douser |
| US2753267A (en) * | 1954-02-08 | 1956-07-03 | Jere Bayard | Flavored drinking straw machine and method |
| US2846313A (en) * | 1956-04-23 | 1958-08-05 | Jere Bayard | Flavored drinking straw |
| US3517884A (en) * | 1968-08-05 | 1970-06-30 | Stephen D Horvath | Spiral drinking straw |
| US3615595A (en) * | 1969-04-08 | 1971-10-26 | Nat Patent Dev Corp | Flavored drinking straw |
| US3905477A (en) * | 1972-03-14 | 1975-09-16 | Union Carbide Corp | Tamperproof pouch label |
| US3980074A (en) * | 1973-07-18 | 1976-09-14 | Beecham Group Limited | Device for the administration of powders |
| US4581013A (en) * | 1982-04-19 | 1986-04-08 | Jane C. A. Hayes | Doser for orally administering medicine |
| US4440207A (en) * | 1982-05-14 | 1984-04-03 | Baxter Travenol Laboratories, Inc. | Antibacterial protective cap for connectors |
| DE3245711A1 (de) * | 1982-12-10 | 1984-06-14 | Deutsche Granini Gmbh & Co Kg, 4800 Bielefeld | Trinkvorrichtung fuer erfrischungsgetraenke |
| US4792333A (en) * | 1986-11-04 | 1988-12-20 | Strawdose, Inc. | Unit dose drug package and administering device |
-
1990
- 1990-01-12 US US07/464,481 patent/US4981468A/en not_active Expired - Fee Related
- 1990-02-08 IL IL9332490A patent/IL93324A/en not_active IP Right Cessation
- 1990-02-08 ZA ZA90945A patent/ZA90945B/xx unknown
- 1990-02-09 DE DE90301427T patent/DE69002345T2/de not_active Expired - Fee Related
- 1990-02-09 EP EP90301427A patent/EP0383503B1/en not_active Expired - Lifetime
- 1990-02-09 AT AT90301427T patent/ATE91878T1/de active
- 1990-02-09 DK DK90301427.2T patent/DK0383503T3/da active
- 1990-02-09 ES ES90301427T patent/ES2043268T3/es not_active Expired - Lifetime
- 1990-02-12 CA CA002009858A patent/CA2009858A1/en not_active Abandoned
- 1990-02-12 NZ NZ232482A patent/NZ232482A/en unknown
- 1990-02-13 KR KR1019900001734A patent/KR900012591A/ko not_active Ceased
- 1990-02-14 AU AU49822/90A patent/AU625179B2/en not_active Ceased
- 1990-02-15 IE IE55990A patent/IE63590B1/en not_active IP Right Cessation
- 1990-02-15 JP JP2035080A patent/JPH02274252A/ja active Pending
- 1990-02-16 HU HU90842A patent/HUT57573A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE63590B1 (en) | 1995-05-17 |
| NZ232482A (en) | 1992-12-23 |
| JPH02274252A (ja) | 1990-11-08 |
| ZA90945B (en) | 1991-10-30 |
| AU625179B2 (en) | 1992-07-02 |
| US4981468A (en) | 1991-01-01 |
| DE69002345T2 (de) | 1993-12-09 |
| HU900842D0 (en) | 1990-04-28 |
| EP0383503B1 (en) | 1993-07-28 |
| DE69002345D1 (de) | 1993-09-02 |
| KR900012591A (ko) | 1990-09-01 |
| HUT57573A (en) | 1991-12-30 |
| EP0383503A1 (en) | 1990-08-22 |
| DK0383503T3 (da) | 1993-09-20 |
| ES2043268T3 (es) | 1993-12-16 |
| CA2009858A1 (en) | 1990-08-17 |
| AU4982290A (en) | 1990-08-23 |
| IE900559L (en) | 1990-08-17 |
| IL93324A0 (en) | 1990-11-29 |
| ATE91878T1 (de) | 1993-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4981468A (en) | Delivery device for orally administered therapeutic agents | |
| JP3285366B2 (ja) | 活性薬剤放出デバイス用の流動制御手段構造 | |
| KR100449538B1 (ko) | 개별유니트의경구투여 | |
| WO2012052853A2 (en) | Oral dosing device for administration of medication | |
| US20110224648A1 (en) | Syringe Filter Cap and Method of Using the Same for Administration of Medication Dosage | |
| EP3628016B1 (en) | System for dosing and dispensing medication | |
| JP3287576B2 (ja) | 別々の単一体の経口投与用複数流路装置 | |
| JP2000509312A (ja) | 活性物質送出装置のクロージャ・システム | |
| EP1629820A1 (en) | Housing body for deglutition of solid molding for oral ingestion, container for the housing body, and deglutition method | |
| AU2002334476A1 (en) | Intraruminal device | |
| WO2003024355A1 (en) | Intraruminal device | |
| US20060043207A1 (en) | Apparatus, kit and related methods for administering substances | |
| ES2659814T3 (es) | Dispositivo para la administración por vía oral de principios activos | |
| US20060147497A1 (en) | Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof | |
| HK1015671B (en) | Oral delivery of discrete units | |
| MXPA98000596A (en) | Oral asset system of discrete agent act units |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| RH1 | Patent not in force |